优化产前糖皮质激素使用时机并避免过度使用
该回顾性队列研究纳入两家学术医院2016至2024年间单胎分娩者,重点分析24 0/7至33 6/7周分娩者产前糖皮质激素给药与分娩的时间关系。1694例早产者中56.7%为最佳时机给药,14.8%未给药;接受 steroids 者中25.9%足月分娩。结论认为达到最佳给药时机仍具挑战,需改进早产预测与个体化评估。
要点
- 早产者中仅56.7%在首剂后6小时至7天内分娩,属最佳时机给药。
- 14.8%早产者未接受产前糖皮质激素,18.9%在给药7天后才分娩。
- 接受 steroids 者中25.9%最终足月分娩,提示存在不必要暴露。
核心结论
- 实现产前糖皮质激素最佳给药时机仍具挑战性。
- 需改进早产预测并对患者个体化评估,以确保高危者及时用药并减少不必要暴露。
研究设计与样本
- 主要队列为妊娠24 0/7至33 6/7周分娩者,共1694例。
- 主要结局为产前糖皮质激素给药与分娩的时间关系,分为未给药、最佳时机(首剂后6小时至7天分娩)和次佳时机(首剂后不足6小时或超过7天分娩)。
- 平衡指标为妊娠34周前接受糖皮质激素且足月(37周后)分娩者。
主要发现
- 1694例34周前分娩者中,961例(56.7%)为最佳时机给药。
- 162例(9.6%)在首剂后不足6小时分娩,320例(18.9%)在给药7天后分娩,251例(14.8%)未接受糖皮质激素。
- 34周前接受糖皮质激素者中,747/2879(25.9%)足月分娩。
- 最佳时机给药率与足月分娩率随孕周变化较小。
关键数值与推荐
- 最佳时机给药定义:首剂产前糖皮质激素后6小时至7天内分娩(SMFM质量指标)。
- 次佳时机给药定义:首剂后不足6小时或超过7天分娩。
临床怎么用
- 应基于早产预测和个体化评估决定产前糖皮质激素给药时机。
- 对妊娠期高血压疾病、早产、胎膜早破者需关注及时给药。
- 对焦虑障碍、无早产史经产妇、前置胎盘、胎盘植入者需警惕给药后延迟分娩导致的不必要暴露。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To provide real-world data to inform benchmarking goals and practical issues that influence optimal antenatal corticosteroid timing and to examine patient factors, such as gestational age at steroid administration and presenting diagnoses, associated with steroid administration in relation to delivery. METHODS: This is a retrospective cohort study of singleton deliveries between July 1, 2016, and December 31, 2024, at two large academic hospitals with level IV neonatal intensive care units in a single health system. The primary cohort of interest was individuals who delivered between 24 0/7 and 33 6/7 weeks of gestation. The primary outcome of interest was the timing of antenatal corticosteroid administration in relation to delivery, categorized as none, delivery between 6 hours and 7 days after the first dose of antenatal corticosteroid ("optimally timed" per the Society for Maternal-Fetal Medicine's quality metric), and delivery less than 6 hours or more than 7 days after the first dose of antenatal corticosteroid ("suboptimally timed"). As a balancing measure to optimally timed antenatal corticosteroid administration, we also examined those who received antenatal corticosteroids before 34 weeks of gestation and delivered at term (after 37 weeks). We reported the rates of optimal timing and term delivery by their corresponding weeks of gestation and performed multivariable logistic regression modeling to understand patient factors and diagnoses associated with antenatal corticosteroid timing. RESULTS: Among the 1,694 pregnant patients who delivered before 34 weeks of gestation, 961 (56.7%) had optimally timed antenatal corticosteroid administration, 162 (9.6%) received the first dose of antenatal corticosteroids less than 6 hours before delivery, 320 (18.9%) delivered more than 7 days after antenatal corticosteroid administration, and 251 (14.8%) did not receive antenatal corticosteroids. Of those who received antenatal steroids before 34 weeks of gestation, 747 of 2,879 (25.9%) delivered at term. There was little variation in optimal timing or term delivery by gestational age. Clinical factors associated with optimally timed antenatal corticosteroid administration compared with delivery more than 7 days after administration included pregnancy-related hypertensive disorder (adjusted odds ratio [aOR] 1.88, 95% CI, 1.31-2.69), preterm labor (aOR 2.78, 95% CI, 1.32-5.81), premature rupture of membranes (1.37, 95% CI, 1.33-1.42), anxiety disorder (aOR 079, 95% CI, 0.76-0.83), multiparous with no history of preterm birth (aOR 0.81, 95% CI, 0.77-0.86), placenta previa (aOR 0.76, 95% CI, 0.68-0.84), and placenta accreta (aOR 0.83, 95% CI, 0.81-0.85). CONCLUSION: Achieving optimal timing of antenatal corticosteroid administration remains challenging. These findings underscore the need for improved prediction of preterm delivery and individualized patient assessment to ensure timely access to antenatal corticosteroids for women at risk of preterm birth while reducing unnecessary exposure.
引用
- Clapp MA, Li S, Melamed A, et al. Maximizing Benefit From Antenatal Steroid Use While Avoiding Overuse. Obstet Gynecol. 2026. PMID: 41643200. doi:10.1097/AOG.0000000000006178
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。